Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 42
- 试验地点
- 1
- 主要终点
- brown adipose tissue activity
研究概览
简要总结
Obesity is epidemic in Australia, and current preventative strategies have had limited success in alleviating this health crisis. While numerous options are available for treatment of obesity, most do not result in sustained weight reduction. Obesity results from an imbalance between energy intake and expenditure, therefore new methods that correct this imbalance are essential for effective long-term treatment. Rodent studies show that brown adipose tissue (BAT) can burn more energy than any other tissue in the body, therefore targeting BAT to increase its activity (energy burning rate) and quantity in humans is potentially a powerful tool for the treatment of obesity and related diseases. BAT has only recently been irrefutably identified in adult humans therefore little is known about how it functions in humans.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 19 Years 至 35 Years(Adult)
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Males aged 19 - 35 years
- •Free of overt coronary disease (on history, medical examination and ECG)
- •Unmedicated
- •No major illness
- •BMI <27 kg/m2
排除标准
- •Unable to give informed consent
- •Participant in research projects involving ionising radiation within the past 5 years.
- •Claustrophobia
- •Fasting plasma glucose > 6.0 mmol/L
研究组 & 干预措施
Placebo
lactose powder in equivalent capsule
干预措施: Placebo (Drug)
Drug treatment
sympathetic agonist and thiazolidinedione
干预措施: Ephedrine, pioglitazone (Drug)
结局指标
主要结局
brown adipose tissue activity
时间窗: 3 years
measured via PET-CT
次要结局
未报告次要终点
